It is a pharma private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2019.
2019 | Visakhapatnam, Andhra Pradesh, India | ActiveAquila Janus Laboratories Private Limited, a active private limited company, was established on 15 April 2019 in Visakhapatnam, Andhra Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24304AP2019PTC111700. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Mohan Prasad Reddi (Director), Bhanu Zippora Muppidi (Director), Stanley Prasan Sundara (Director). Past directors included Mohan Prasad Reddi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 7-5-141, Eastern Avenue Apartments, Panduranga Puram,, Visakhapatnam, Andhra Pradesh, 530003.
U24304AP2019PTC111700
111700
15 April 2019
₹1.00 M
₹1.00 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Aquila Janus Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohan Prasad Reddi | Director | 24 Jan 2020 | Current |
| Bhanu Zippora Muppidi | Director | 15 Apr 2019 | Current |
| Stanley Prasan Sundara | Director | 15 Apr 2019 | Current |
| Sandhya Sundara | Director | 15 Apr 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aquila Janus Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.6% decrease. The company also saw a substantial fall in profitability, with a 40.01% decrease in profit. The company's net worth Soared by an impressive increase of 18.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Aquila Janus Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aquila Janus Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aquila Janus Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquila Janus Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aquila Janus Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Aquila Janus Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was completed.
The activity Mohan Prasad Reddi was appointed as a Director was appointed as a Director on 24 Jan 2020 & has been associated with this company since 5 years 10 months . was completed.
The activity Bhanu Zippora Muppidi was appointed as a Director was appointed as a Director on 15 Apr 2019 & has been associated with this company since 6 years 8 months . was completed.
Stanley Prasan Sundara was appointed as a Director was appointed as a Director on 15 Apr 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.
Sandhya Sundara was appointed as a Director was appointed as a Director on 15 Apr 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.
The CIN of Aquila Janus Laboratories Private Limited is U24304AP2019PTC111700.
Aquila Janus Laboratories Private Limited is headquartered at 7-5-141, Eastern Avenue Apartments, Panduranga Puram,, Visakhapatnam, Andhra Pradesh, 530003.
Aquila Janus Laboratories Private Limited was incorporated on 15 April 2019.
The current directors of Aquila Janus Laboratories Private Limited are
The primary industry of Aquila Janus Laboratories Private Limited is Trade.
Aquila Janus Laboratories Private Limited is unlisted.
The authorized capital of Aquila Janus Laboratories Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX